Food Policy & Law FDA Warning Letters: Misbranding, Inadequate HACCP Plans, Excessive Drug Residues The latest round of warning letters from the U.S. Food and Drug Administration (FDA) include a dairy company cited for inaccurate nutritional claims, two seafood processors for inadequate HACCP By News Desk / 27 Oct 2014